Outstanding clinical qualities

The clinical qualities of Photopharmica’s PDT technology are exceptional, giving it the potential to become the preferred topical antimicrobial for physicians. These qualities include:

Highly selective targeting

- the unique selectivity or targeting ability of the technology makes it possible to kill target microorganisms with no significant damage to healthy tissue.

Broad spectrum activity

– Photopharmica’s PDT technology can be used to kill a wide range of microorganisms, including all tested aerobic, anaerobic, Gram negative, Gram positive and antibiotic resistant bacteria, fungi and parasites

Very low risk of acquired resistance

– The mode of action destroys or disrupts many critical microbial cell processes within a target organism. It is extremely unlikely that any micro-organism could develop resistance against all of these lethal processes, which has also been confirmed by rigorous laboratory studies

Short treatment times

– treatment time using PPA904 PDT in chronic wounds is approximately 30 minutes

Attractive to patients

– the treatment is almost painless, unlike other topical PDT drug candidates where pain may arise from the accumulation of photosensitiser in nerve endings